Similar articles

• Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

  Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA. Nakagomi T, et al. Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4. Arch Virol. 2008. PMID: 18175037
• RotaTeq: a new oral rotavirus vaccine.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2006 Jul 31;48(1240):61-3. Med Lett Drugs Ther. 2006. PMID: 16874281 No abstract available.
• Live attenuated human rotavirus vaccine, Rotarix.

  Bernstein DI. Bernstein DI. Semin Pediatr Infect Dis. 2006 Oct;17(4):188-94. doi: 10.1053/j.spid.2006.08.006. Semin Pediatr Infect Dis. 2006. PMID: 17055369 Review.
• Rotavirus vaccination.

  Bjur KA, Jacobson RM. Bjur KA, et al. Minerva Pediatr. 2009 Oct;61(5):515-21. Minerva Pediatr. 2009. PMID: 19794377
• Rotavirus vaccine: early introduction in Latin America-risks and benefits.

  Pérez-Vargas J, Isa P, López S, Arias CF. Pérez-Vargas J, et al. Arch Med Res. 2006 Jan;37(1):1-10. doi: 10.1016/j.arcmed.2005.06.004. Arch Med Res. 2006. PMID: 16314179 Review.